Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecillinam for Treatment of Genital Chlamydia Infection in Asymptomatic Men
2013-002379-17Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pivmecillinam in Chlamydia trachomatis infection, sponsored by Oslo University Hospital. Primary endpoint: Microbiological cure (test of cure). Started Dec 2013; status: completed.
02
Drugs
pivmecillinam
03
Conditions
Chlamydia trachomatis infection
Beyond the preview
Go deeper on 2013-002379-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002379-17.